ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features

Jiaqi Li,Zhenbin Qiu,Chao Zhang,Sijie Chen,Mengmin Wang,Qiuchen Meng,Haiming Lu,Lei Wei,Hairong Lv,Wenzhao Zhong,Xuegong Zhang
DOI: https://doi.org/10.1007/s00330-022-09055-0
IF: 7.034
2022-08-24
European Radiology
Abstract:ObjectivesTo quantify intra-tumor heterogeneity (ITH) in non-small cell lung cancer (NSCLC) from computed tomography (CT) images.MethodsWe developed a quantitative ITH measurement—ITHscore—by integrating local radiomic features and global pixel distribution patterns. The associations of ITHscore with tumor phenotypes, genotypes, and patient’s prognosis were examined on six patient cohorts (n = 1399) to validate its effectiveness in characterizing ITH.ResultsFor stage I NSCLC, ITHscore was consistent with tumor progression from stage IA1 to IA3 (p < 0.001) and captured key pathological change in terms of malignancy (p < 0.001). ITHscore distinguished the presence of lymphovascular invasion (p = 0.003) and pleural invasion (p = 0.001) in tumors. ITHscore also separated patient groups with different overall survival (p = 0.004) and disease-free survival conditions (p = 0.005). Radiogenomic analysis showed that the level of ITHscore in stage I and stage II NSCLC is correlated with heterogeneity-related pathways. In addition, ITHscore was proved to be a stable measurement and can be applied to ITH quantification in head-and-neck cancer (HNC).ConclusionsITH in NSCLC can be quantified from CT images by ITHscore, which is an indicator for tumor phenotypes and patient’s prognosis.Key Points• ITHscore provides a radiomic quantification of intra-tumor heterogeneity in NSCLC.• ITHscore is an indicator for tumor phenotypes and patient’s prognosis.• ITHscore has the potential to be generalized to other cancer types such as HNC.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?